Fluticasone Propionate Aerosol, Metered
Product Images NDC 50090-6053

Product Visual Gallery

This gallery contains 15 technical images submitted to the FDA as part of the official labeling for Fluticasone Propionate (NDC 50090-6053). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by A-s Medication Solutions, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Fluticasone Propionate Chemical Structure (Fluticasonepropionatehfa Spl Graphic 01)

Chemical structure of fluticasone propionate, the active ingredient in Fluticasone Propionate HFA inhalation aerosol. The diagram depicts the molecular formula with labeled atoms and bonds.*

FDA Label Image

Figure 1. A 12-week Clinical Trial In Subjects Aged 12 Years And Older Inadequately Controlled On Bronchodilators Alone: Mean Percent Change From Baseline In Fev1 Prior To Am Dose (trial 1) (Fluticasonepropionatehfa Spl Graphic 02)

A line graph displaying the percentage change from baseline in FEV1 over 12 weeks and at an endpoint for two groups: placebo and Fluticasone Propionate HFA 88 mcg twice daily. The graph shows higher improvement in FEV1 for the Fluticasone Propionate group compared to placebo over time.*

FDA Label Image

Figure 2. A 12-week Clinical Trial In Subjects Aged 12 Years And Older Already Receiving Daily Inhaled Corticosteroids: Mean Percent Change From Baseline In Fev1 Prior To Am Dose (trial 2) (Fluticasonepropionatehfa Spl Graphic 03)

A line graph depicting the percent change from baseline in FEV1 over 12 weeks for placebo and three different doses of Fluticasone Propionate HFA (88 mcg, 220 mcg, and 440 mcg, all administered twice daily). The x-axis represents time in weeks, and the y-axis shows percent change from baseline in FEV1. Data points for each group are represented by different symbols as indicated in the legend.*

FDA Label Image

Figure 3. A 16-week Clinical Trial In Subjects Aged 12 Years And Older Requiring Chronic Oral Prednisone Therapy: Change In Maintenance Prednisone Dose (Fluticasonepropionatehfa Spl Graphic 04)

A bar chart showing percentage of subjects by dose reduction and increase. It compares placebo, Fluticasone Propionate HFA 440 mcg twice daily, and Fluticasone Propionate HFA 880 mcg twice daily groups. The chart displays higher dose reduction percentages for the fluticasone groups and minimal dose increase for these groups compared to placebo.*

FDA Label Image

Figure A (Fluticasonepropionatehfa Spl Graphic 05)

Illustration showing parts of a Fluticasone Propionate HFA metered aerosol inhaler including a metal canister, dark orange plastic actuator, dark orange mouthpiece, a dose counter, and a separate peach-colored cap.*

FDA Label Image

Figure B (Fluticasonepropionatehfa Spl Graphic 06)

Instructional illustration showing a person removing the protective cap from a Fluticasone Propionate HFA inhaler by holding the cap with one hand and the inhaler with the other hand, preparing it for use by respiratory inhalation.*

FDA Label Image

Figure C (Fluticasonepropionatehfa Spl Graphic 07)

An instructional illustration showing a person using a metered-dose inhaler. The image demonstrates holding the inhaler upright, pressing down on the top to release a spray, and inhaling the medication through the mouthpiece. An arrow indicates the spray direction toward the mouth.*

FDA Label Image

Figure D (Fluticasonepropionatehfa Spl Graphic 08)

An instructional illustration showing a hand holding an inhaler device labeled "1200." The image demonstrates grasping and pressing the top of the aerosol inhaler for use.*

FDA Label Image

Figure E (Fluticasonepropionatehfa Spl Graphic 09)

An illustration showing the correct Mouthpiece-Down position for using a fluticasone propionate aerosol inhaler. The inhaler has a dark orange mouthpiece and a peach-colored cap placed separately below. A hand is holding the inhaler in position, demonstrating proper use.*

FDA Label Image

Figure F (Fluticasonepropionatehfa Spl Graphic 10)

An instructional illustration showing a person's side profile with an arrow directing air outward from the mouth. Text instructs to "Breathe out as much air as you can," indicating a step in proper inhaler use or respiratory technique.*

FDA Label Image

Figure G (Fluticasonepropionatehfa Spl Graphic 11)

An instructional illustration showing a person using an inhaler. The image directs the user to push down on the inhaler and breathe in through the mouthpiece, with a dashed arrow indicating the airflow into the mouth.*

FDA Label Image

Figure H (Fluticasonepropionatehfa Spl Graphic 12)

An instructional illustration showing a person rinsing their mouth and spitting into a sink, with a glass of water nearby. This diagram likely demonstrates proper oral hygiene after using a respiratory inhalation aerosol.*

FDA Label Image

Figure I (Fluticasonepropionatehfa Spl Graphic 13)

Illustration showing proper use of Fluticasone Propionate HFA aerosol inhaler with two panels: the top panel labeled 'Not blocked' depicting unobstructed spray from the mouthpiece; the bottom panel labeled 'Blocked' showing spray obstructed by a blocked mouthpiece. The diagram highlights correct inhaler use for respiratory delivery.*

FDA Label Image

Figure J (Fluticasonepropionatehfa Spl Graphic 14)

An instructional illustration showing a finger pressing down on the actuator of a metered dose inhaler, with an arrow indicating a twisting or turning motion. The image demonstrates how to activate or prepare the inhaler for use.*

FDA Label Image

Label Image (Lbl500906053)

Fluticasone Propionate HFA 44 mcg metered aerosol inhaler label from A-S Medication Solutions. The label includes directions for use, storage instructions (store at 68 to 77 degrees F, away from heat and mouthpiece down), net weight of 10.6 g, and quantity of 120 metered actuations. The NDC is 50090-6053.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.